NVRO Nevro Corp
Price (delayed)
$5.84
Market cap
$221.21M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.06
Enterprise value
$377.32M
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain.
Highlights
The net income has plunged by 64% from the previous quarter and by 23% YoY
The EPS has dropped by 63% since the previous quarter and by 20% year-on-year
Key stats
What are the main financial stats of NVRO
Market
Valuations
Earnings
Shares outstanding
37.88M
Market cap
$221.21M
Enterprise value
$377.32M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.95
Price to sales (P/S)
0.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.92
Revenue
$408.52M
Gross profit
$269.53M
Operating income
-$132.91M
Net income
-$113.44M
EBIT
-$85.46M
EBITDA
-$71.35M
Free cash flow
-$29.23M
Per share
Balance sheet
Liquidity
EPS
-$3.06
EPS diluted
-$3.06
Free cash flow per share
-$0.79
Book value per share
$6.16
Revenue per share
$11.01
TBVPS
$14.27
Total assets
$553.84M
Total liabilities
$322.83M
Debt
$251.16M
Equity
$231.01M
Working capital
$373.06M
Debt to equity
1.09
Current ratio
4.62
Quick ratio
3.54
Net debt/EBITDA
-2.19
Margins
Efficiency
Dividend
EBITDA margin
-17.5%
Gross margin
66%
Net margin
-27.8%
Operating margin
-32.5%
Return on assets
-19.3%
Return on equity
-42.9%
Return on invested capital
-14.3%
Return on capital employed
-19%
Return on sales
-20.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NVRO stock price
How has the Nevro stock price performed over time
Intraday
0%
1 week
-0.17%
1 month
2.1%
1 year
-54.12%
YTD
56.99%
QTD
0%
Financial performance
How have Nevro's revenue and profit performed over time
Revenue
$408.52M
Gross profit
$269.53M
Operating income
-$132.91M
Net income
-$113.44M
Gross margin
66%
Net margin
-27.8%
The net margin has dropped by 68% since the previous quarter and by 28% year-on-year
The net income has plunged by 64% from the previous quarter and by 23% YoY
The operating margin has plunged by 63% from the previous quarter and by 39% YoY
NVRO's operating income has shrunk by 59% QoQ and by 34% YoY
Growth
What is Nevro's growth rate over time
Valuation
What is Nevro stock price valuation
P/E
N/A
P/B
0.95
P/S
0.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.92
The EPS has dropped by 63% since the previous quarter and by 20% year-on-year
NVRO's P/B is 86% below its 5-year quarterly average of 7.0 and 14% below its last 4 quarters average of 1.1
The equity has contracted by 21% YoY and by 16% from the previous quarter
The P/S is 91% lower than the 5-year quarterly average of 6.1 and 24% lower than the last 4 quarters average of 0.7
The revenue has contracted by 3.9% YoY and by 2.5% from the previous quarter
Efficiency
How efficient is Nevro business performance
NVRO's return on equity has dropped by 73% since the previous quarter and by 37% year-on-year
The return on sales has dropped by 70% since the previous quarter
The ROA has plunged by 69% from the previous quarter and by 22% YoY
The company's return on invested capital has shrunk by 66% QoQ but it rose by 2.1% YoY
Dividends
What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NVRO.
Financial health
How did Nevro financials performed over time
NVRO's total assets is 72% greater than its total liabilities
NVRO's quick ratio is down by 27% year-on-year and by 3% since the previous quarter
Nevro's current ratio has decreased by 27% YoY and by 8% QoQ
The debt is 9% greater than the equity
The debt to equity has increased by 47% YoY and by 21% QoQ
The equity has contracted by 21% YoY and by 16% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.